The Discounted Cash Flow (DCF) valuation of GlaxoSmithKline PLC (GSK.L) is 2,002.77 GBP. With the latest stock price at 2,144.00 GBP, the upside of GlaxoSmithKline PLC based on DCF is -6.6%.
Based on the latest price of 2,144.00 GBP and our DCF valuation, GlaxoSmithKline PLC (GSK.L) is a sell. selling GSK.L stocks now will result in a potential gain of 6.6%.
| Range | Selected | |
| WACC / Discount Rate | 9.0% - 11.1% | 10.0% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 1,592.12 - 2,686.96 | 2,002.77 |
| Upside | -25.7% - 25.3% | -6.6% |